David A. Hokey

3.1k total citations
44 papers, 1.5k citations indexed

About

David A. Hokey is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, David A. Hokey has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 26 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in David A. Hokey's work include Tuberculosis Research and Epidemiology (25 papers), Immunotherapy and Immune Responses (19 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). David A. Hokey is often cited by papers focused on Tuberculosis Research and Epidemiology (25 papers), Immunotherapy and Immune Responses (19 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). David A. Hokey collaborates with scholars based in United States, Netherlands and Denmark. David A. Hokey's co-authors include David B. Weiner, Louis D. Falo, Zhengrong Cui, Jian Yan, Weihsu Chen, Leaf Huang, Peter Andersen, Ingrid Kromann, Søren T. Hoff and Andrew J. Graves and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David A. Hokey

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Hokey United States	21	1.0k	665	428	407	156	44	1.5k
Marta Sánchez‐Hernández Netherlands	7	1.1k 1.0×	373 0.6×	341 0.8×	318 0.8×	99 0.6×	9	1.6k
Marcin Kwissa United States	16	1.3k 1.3×	496 0.7×	662 1.5×	433 1.1×	137 0.9×	19	2.0k
Ross Lindsay United States	13	1.2k 1.1×	458 0.7×	355 0.8×	581 1.4×	207 1.3×	26	1.8k
Hillarie Plessner Windish United States	13	782 0.7×	475 0.7×	363 0.8×	409 1.0×	64 0.4×	15	1.2k
Arun T. Kamath Australia	22	1.9k 1.8×	679 1.0×	470 1.1×	512 1.3×	45 0.3×	27	2.4k
Magdalini Moutaftsi United States	15	931 0.9×	302 0.5×	586 1.4×	492 1.2×	335 2.1×	19	1.5k
Thomas M. Kaufman United States	15	534 0.5×	669 1.0×	282 0.7×	665 1.6×	149 1.0×	26	1.3k
Barbara J. Flynn United States	14	1.7k 1.7×	499 0.8×	514 1.2×	713 1.8×	348 2.2×	19	2.4k
Frédéric Martinon France	21	986 0.9×	449 0.7×	684 1.6×	324 0.8×	379 2.4×	54	1.8k
Lenette L. Lu United States	10	480 0.5×	464 0.7×	263 0.6×	292 0.7×	66 0.4×	22	967

Countries citing papers authored by David A. Hokey

Since Specialization

Citations

This map shows the geographic impact of David A. Hokey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Hokey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Hokey more than expected).

Fields of papers citing papers by David A. Hokey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Hokey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Hokey. The network helps show where David A. Hokey may publish in the future.

Co-authorship network of co-authors of David A. Hokey

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Hokey. A scholar is included among the top collaborators of David A. Hokey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Hokey. David A. Hokey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tait, Dereck, Andreas H. Diacon, Álvaro H. Borges, et al.. (2024). Safety and Immunogenicity of the H56:IC31 Tuberculosis Vaccine Candidate in Adults Successfully Treated for Drug-Susceptible Pulmonary Tuberculosis: A Phase 1 Randomized Trial. The Journal of Infectious Diseases. 230(5). 1262–1270. 6 indexed citations

Sivakumaran, Dhanasekaran, Gretta Blatner, David A. Hokey, et al.. (2021). A 2-Dose AERAS-402 Regimen Boosts CD8+ Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients. Frontiers in Immunology. 12. 673532–673532. 10 indexed citations

Hokey, David A., Timothy Lahey, Alice Halliday, et al.. (2019). CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: A randomized, placebo-controlled trial. PLoS ONE. 14(5). e0217091–e0217091. 17 indexed citations

Suliman, Sara, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.. (2018). Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial. American Journal of Respiratory and Critical Care Medicine. 199(2). 220–231. 76 indexed citations

Zelmer, Andrea, Rachel Tanner, Elena Stylianou, et al.. (2016). A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. BMC Infectious Diseases. 16(1). 412–412. 26 indexed citations

Nyendak, Melissa, Gwendolyn Swarbrick, Meghan Cansler, et al.. (2016). Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine. Scientific Reports. 6(1). 36355–36355. 25 indexed citations

Hokey, David A., Michèle Tameris, Veerabadran Dheenadhayalan, et al.. (2015). Safety and immunogenicity of the Ad35/AERAS-402 tuberculosis vaccine in a phase 2 dose-finding clinical trial in BCG-vaccinated healthy infants (VAC5P.1119). The Journal of Immunology. 194(1_Supplement). 73.4–73.4. 2 indexed citations

Jenum, Synne, Harleen M. S. Grewal, David A. Hokey, et al.. (2014). The Frequencies of IFNγ+IL2+TNFα+ PPD-Specific CD4+CD45RO+ T-Cells Correlate with the Magnitude of the QuantiFERON® Gold In-Tube Response in a Prospective Study of Healthy Indian Adolescents. PLoS ONE. 9(7). e101224–e101224. 9 indexed citations

Hokey, David A.. (2014). TB Vaccines: The (Human) Challenge Ahead. PubMed. 4(4). e128–e128. 7 indexed citations

10.

Hokey, David A., Patricia A. Darrah, Diane L. Bolton, et al.. (2014). A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine. Human Vaccines & Immunotherapeutics. 10(8). 2199–2210. 19 indexed citations

11.

Darrah, Patricia A., Diane L. Bolton, Andrew A. Lackner, et al.. (2014). Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge. The Journal of Immunology. 193(4). 1799–1811. 70 indexed citations

12.

Zhang, Jing, Ming Guo, Zhixiang Huang, et al.. (2014). Mycobacterium tuberculosis Erdman infection of rhesus macaques of Chinese origin. Tuberculosis. 94(6). 634–643. 13 indexed citations

13.

Hokey, David A. & Ann M. Ginsberg. (2013). The current state of tuberculosis vaccines. Human Vaccines & Immunotherapeutics. 9(10). 2142–2146. 23 indexed citations

14.

Graves, Andrew J. & David A. Hokey. (2011). Tuberculosis Vaccines: Review of Current Development Trends and Future Challenges. s1. 7 indexed citations

15.

Hirao, Lauren A., David A. Hokey, Matthew P. Morrow, Maria Jure–Kunkel, & David B. Weiner. (2011). Immune Modulation through 4-1BB Enhances SIV Vaccine Protection in Non-Human Primates against SIVmac251 Challenge. PLoS ONE. 6(9). e24250–e24250. 16 indexed citations

16.

Hokey, David A. & Amit Misra. (2010). Aerosol vaccines for tuberculosis: A fine line between protection and pathology. Tuberculosis. 91(1). 82–85. 23 indexed citations

17.

Hirao, Lauren A., Ling Wu, Amir Sada Khan, et al.. (2008). Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques. Vaccine. 26(25). 3112–3120. 111 indexed citations

18.

Nayak, Jayakar V., David A. Hokey, Adriana T. Larregina, et al.. (2006). Phagocytosis Induces Lysosome Remodeling and Regulated Presentation of Particulate Antigens by Activated Dendritic Cells. The Journal of Immunology. 177(12). 8493–8503. 18 indexed citations

19.

Cui, Zhengrong, et al.. (2006). Immunostimulation of dendritic cells by cationic liposomes. Molecular Membrane Biology. 23(5). 385–395. 159 indexed citations

20.

Hokey, David A., Adriana T. Larregina, Géza Erdös, Simon C. Watkins, & Louis D. Falo. (2005). Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity. Cancer Research. 65(21). 10059–10067. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact